We also demonstrate the chemosensitization of drug-resistant BC cells by the Anthos in combination with the chemo drug, PAC, and investigate the mechanism underlying the anti-cancer and anti-metastatic effects of the Anthos, with respect to the NF-κB signaling pathway, as well as metastatic and angiogenic mediators. Here, NFKB1 is linked to cancer.